(KO) The Coca-Cola - Overview
Stock: Cola, Water, Juice, Tea, Sports
| Risk 5d forecast | |
|---|---|
| Volatility | 17.1% |
| Relative Tail Risk | -4.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 13.36 |
| Character TTM | |
|---|---|
| Beta | 0.042 |
| Beta Downside | 0.033 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.27% |
| CAGR/Max DD | 0.74 |
EPS (Earnings per Share)
Revenue
Description: KO The Coca-Cola January 26, 2026
The Coca-Cola Company (NYSE: KO) is a global non-alcoholic beverage producer headquartered in Atlanta, Georgia, with a product lineup that spans sparkling soft drinks, water, sports, coffee, tea, juice, dairy-alternatives, and plant-based drinks, sold under more than 30 brand names including Coca-Cola, Sprite, Fanta, Dasani, Powerade, and Costa.
Its commercial model relies on a vast network of independent bottling partners, distributors, wholesalers, and retailers, which handle the manufacturing, bottling, and point-of-sale distribution for both fountain syrups and packaged beverages across the United States and over 200 international markets.
According to the company’s FY 2023 Form 10-K (filed February 2024), Coca-Cola generated $46.9 billion in net operating revenue, a 5 % year-over-year increase driven primarily by a 9 % rise in its non-carbonated beverage segment. Comparable diluted earnings per share were $2.73, and the operating margin held at 27 % despite higher commodity costs. The “Zero-Sugar” portfolio contributed a 12 % volume gain, while the newly acquired Costa coffee chain added $1.2 billion in net revenue, reflecting continued diversification beyond traditional sodas.
Key macro-economic drivers affecting KO include: (1) commodity price volatility-sugar and aluminum prices were up ~15 % and ~10 % YoY in 2023, pressuring input costs; (2) shifting consumer preferences toward low-calorie and functional beverages, which is accelerating growth in the “Zero-Sugar” and sports-drink categories; and (3) emerging-market income growth, where per-capita soda consumption is still expanding, supporting long-term volume upside. Inflationary pressures have led the company to implement price increases averaging 3-4 % across its core markets in 2023, partially offsetting cost inflation.
For a deeper, data-driven valuation of KO, you may find ValueRay’s analytics platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 13.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 20.36% < 20% (prev 1.59%; Δ 18.78% < -1%) |
| CFO/TA 0.07 > 3% & CFO 7.41b > Net Income 13.11b |
| Net Debt (35.22b) to EBITDA (18.47b): 1.91 < 3 |
| Current Ratio: 1.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago -0.16% < -2% |
| Gross Margin: 61.63% > 18% (prev 0.61%; Δ 6102 % > 0.5%) |
| Asset Turnover: 46.69% > 50% (prev 46.80%; Δ -0.12% > 0%) |
| Interest Coverage Ratio: 8.62 > 6 (EBITDA TTM 18.47b / Interest Expense TTM 1.65b) |
Altman Z'' 5.06
| A: 0.09 (Total Current Assets 31.04b - Total Current Liabilities 21.28b) / Total Assets 104.82b |
| B: 0.77 (Retained Earnings 80.38b / Total Assets 104.82b) |
| C: 0.14 (EBIT TTM 14.26b / Avg Total Assets 102.68b) |
| D: 0.96 (Book Value of Equity 68.01b / Total Liabilities 70.54b) |
| Altman-Z'' Score: 5.06 = AAA |
Beneish M -3.11
| DSRI: 0.84 (Receivables 3.04b/3.57b, Revenue 47.94b/47.06b) |
| GMI: 0.99 (GM 61.63% / 61.06%) |
| AQI: 0.98 (AQ_t 0.61 / AQ_t-1 0.63) |
| SGI: 1.02 (Revenue 47.94b / 47.06b) |
| TATA: 0.05 (NI 13.11b - CFO 7.41b) / TA 104.82b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of KO shares?
Over the past week, the price has changed by +0.91%, over one month by +11.63%, over three months by +12.10% and over the past year by +17.31%.
Is KO a buy, sell or hold?
- StrongBuy: 14
- Buy: 8
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.5 | 4.8% |
| Analysts Target Price | 82.5 | 4.8% |
| ValueRay Target Price | 88.8 | 12.9% |
KO Fundamental Data Overview February 14, 2026
P/E Forward = 24.5098
P/S = 7.0597
P/B = 10.5638
P/EG = 2.4782
Revenue TTM = 47.94b USD
EBIT TTM = 14.26b USD
EBITDA TTM = 18.47b USD
Long Term Debt = 42.12b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 45.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.22b USD (from netDebt column, last quarter)
Enterprise Value = 373.67b USD (338.45b + Debt 45.49b - CCE 10.27b)
Interest Coverage Ratio = 8.62 (Ebit TTM 14.26b / Interest Expense TTM 1.65b)
EV/FCF = 70.56x (Enterprise Value 373.67b / FCF TTM 5.30b)
FCF Yield = 1.42% (FCF TTM 5.30b / Enterprise Value 373.67b)
FCF Margin = 11.05% (FCF TTM 5.30b / Revenue TTM 47.94b)
Net Margin = 27.34% (Net Income TTM 13.11b / Revenue TTM 47.94b)
Gross Margin = 61.63% ((Revenue TTM 47.94b - Cost of Revenue TTM 18.40b) / Revenue TTM)
Gross Margin QoQ = 60.05% (prev 61.49%)
Tobins Q-Ratio = 3.57 (Enterprise Value 373.67b / Total Assets 104.82b)
Interest Expense / Debt = 0.95% (Interest Expense 431.0m / Debt 45.49b)
Taxrate = 21.81% (646.0m / 2.96b)
NOPAT = 11.15b (EBIT 14.26b * (1 - 21.81%))
Current Ratio = 1.46 (Total Current Assets 31.04b / Total Current Liabilities 21.28b)
Debt / Equity = 1.41 (Debt 45.49b / totalStockholderEquity, last quarter 32.17b)
Debt / EBITDA = 1.91 (Net Debt 35.22b / EBITDA 18.47b)
Debt / FCF = 6.65 (Net Debt 35.22b / FCF TTM 5.30b)
Total Stockholder Equity = 29.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.76% (Net Income 13.11b / Total Assets 104.82b)
RoE = 44.35% (Net Income TTM 13.11b / Total Stockholder Equity 29.55b)
RoCE = 19.90% (EBIT 14.26b / Capital Employed (Equity 29.55b + L.T.Debt 42.12b))
RoIC = 14.42% (NOPAT 11.15b / Invested Capital 77.34b)
WACC = 5.44% (E(338.45b)/V(383.94b) * Re(6.07%) + D(45.49b)/V(383.94b) * Rd(0.95%) * (1-Tc(0.22)))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.20%
[DCF Debug] Terminal Value 85.86% ; FCFF base≈5.07b ; Y1≈4.84b ; Y5≈4.67b
Fair Price DCF = 24.39 (EV 140.15b - Net Debt 35.22b = Equity 104.93b / Shares 4.30b; r=5.90% [WACC]; 5y FCF grow -5.97% → 2.90% )
EPS Correlation: 24.65 | EPS CAGR: -2.59% | SUE: 1.42 | # QB: 3
Revenue Correlation: 64.69 | Revenue CAGR: 3.24% | SUE: -1.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.82 | Chg30d=-0.021 | Revisions Net=-1 | Analysts=15
EPS current Year (2026-12-31): EPS=3.23 | Chg30d=+0.010 | Revisions Net=-2 | Growth EPS=+7.7% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=3.46 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+7.2% | Growth Revenue=+2.9%